| 书目名称 | Mid-size Drugs Based on Peptides and Peptidomimetics | | 副标题 | A New Drug Category | | 编辑 | Hirokazu Tamamura,Takuya Kobayakawa,Nami Ohashi | | 视频video | | | 概述 | Explains cutting-edge technical terms and new vocabulary clearly.Provides sequentially ordered descriptions ranging from basic concepts to various applications.Includes easy-to-understand figures that | | 丛书名称 | SpringerBriefs in Pharmaceutical Science & Drug Development | | 图书封面 |  | | 描述 | This brief describes studies conducted by the authors on mid-size drugs utilizing peptides and peptidomimetics, and on the development of anti-HIV agents. Peptides are important biological molecules and have various physiological actions. Peptide-based drug discovery may help bring about the development of useful medicines that are highly safe and show potent pharmacological effects in small doses. Recently, it has been shown that there is an important drug-like space in the mid-sized region between low- and high-molecular-weight compounds. Thus, mid-size drugs such as peptide compounds are being focused on. To date, several peptidomimetics that mimic primary, secondary, and tertiary structures of peptides have been developed to maintain and improve biological activities and actions of peptides. In this book, the features and advantages of mid-size drugs are described in detail. In addition, the merits of utilizing peptidomimetics in the development of mid-size drugs are referred to. Understanding such peptide-derived mid-size drugs will lead to a comprehensive expansion of medicinal chemistry. | | 出版日期 | Book 2018 | | 关键词 | Mid-size drug; Cyclic peptide; Peptidomimetic; Administration route; Anti-HIV agent | | 版次 | 1 | | doi | https://doi.org/10.1007/978-981-10-7691-6 | | isbn_softcover | 978-981-10-7690-9 | | isbn_ebook | 978-981-10-7691-6Series ISSN 1864-8118 Series E-ISSN 1864-8126 | | issn_series | 1864-8118 | | copyright | The Author(s) 2018 |
The information of publication is updating
|
|
发表于 2025-3-21 19:54:31
